MSK Ventures is a key program within the MSK Commercialization Ecosystem, with executive leadership from Anaeze Offodile II, MD, MPH, MSK’s Executive Vice President and Chief Strategy Officer. Whitney ...

Our research group has two primary focuses. One part of the lab focuses on determining the mechanisms of intracellular ion and metabolite transport, while the second studies protein nucleic acid ...

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are ...

Soft tissue sarcoma, a diverse group of cancers that arise in the body’s connective tissue, is difficult to treat after it has spread. MSK clinicians are investigating the use of immunotherapy to ...

How are new targeted therapies for specific genetic mutations improving lung cancer treatment? We are getting new targeted therapies approved every year for genes that were long thought to be ...

If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...

Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA can inactivate tumor-suppressing proteins and thereby promote cancer. The ...

What do we know about the relationship between soy and breast cancer? Soy has been found to not only reduce the risk of cancer but also the risk of it coming back. One study showed a 30% reduction in ...

Ready to start planning your care? Call us at 646-926-0945 to make an appointment.

Ready to start planning your care? Call us at 646-926-0945 to make an appointment.

For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for more than 30 years. It was approved by the FDA in 1990 — it was, in fact, the first ever ...

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...